These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2743926)

  • 21. Dose-dependent response of central dopaminergic systems to buspirone in mice.
    Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Gursale SC; Balsara JJ
    Indian J Exp Biol; 2008 Oct; 46(10):704-14. PubMed ID: 19024168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Afobazole decreases motor side effects induced by haloperidol].
    Seredenin SB; Garibova TA; Kuznetsova AL; Voronin MV; Iarkova MA; Voronina TA
    Eksp Klin Farmakol; 2009; 72(1):15-8. PubMed ID: 19334504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity.
    Balsamo A; Lapucci A; Macchia M; Martinelli A; Nencetti S; Rossello A; Cristina T
    Farmaco; 1994 Feb; 49(2):77-82. PubMed ID: 8003184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of antidepressants on L-5HTP-induced changes in rat plasma corticosteroids.
    Lahti RA; Barsuhn C
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):343-9. PubMed ID: 6967219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of cortical neuron responses to acetylcholine by viloxazine.
    Jones RS; Roberts MH
    J Pharm Pharmacol; 1979 Feb; 31(2):87-90. PubMed ID: 33258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of viloxazine hydrochloride on cerebral oxidative metabolism in the rat in vitro].
    Dueñas Laita A; García Roldán JL; González JL; Velasco Martín A
    Arch Neurobiol (Madr); 1983; 46(1):23-30. PubMed ID: 6882108
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of an imidazobenzodiazepine (RO 15-1788) on aggressive behavior in mice].
    Vasar EE; Maĭmets MO; Riago LK; Nurk AM; Allikmets LKh
    Biull Eksp Biol Med; 1984 Oct; 98(10):441-3. PubMed ID: 6208949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: interactions with reserpine.
    Cuomo V; Cagiano R; Brunello N; Fumagalli R; Racagni G
    Neurosci Lett; 1983 Oct; 40(3):315 -9. PubMed ID: 6646506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the effect of viloxazine in the sexual sphere. Double-blind study versus placebo].
    De Leo D
    Clin Ter; 1985 Nov; 115(4):253-9. PubMed ID: 4085181
    [No Abstract]   [Full Text] [Related]  

  • 32. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The responsiveness of cerebral cortical adrenergic receptors after chronic administration of atypical antidepressant mianserin.
    Nalepa I; Vetulani J
    J Psychiatry Neurosci; 1994 Mar; 19(2):120-8. PubMed ID: 8204564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of postsynaptic noradrenergic receptors in the mechanism of action of antidepressants].
    Cuenca E
    Encephale; 1981; 7(4 Suppl):397. PubMed ID: 7318756
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of viloxazine on cortical neurone responses to monoamines and acetylcholine [proceedings].
    Jones RS; Roberts MH
    Br J Pharmacol; 1977 Mar; 59(3):460P. PubMed ID: 843706
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
    Rogoz Z; Wrobel A; Dlaboga D; Maj J; Dziedzicka-Wasylewska M
    J Physiol Pharmacol; 2002 Mar; 53(1):105-16. PubMed ID: 11939713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of monoamine responses of denervated cells by a noradrenaline uptake inhibitor (viloxazine) [proceedings].
    Jones RS; Roberts MH
    Br J Pharmacol; 1978 Mar; 62(3):403P-404P. PubMed ID: 638334
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experiments of the viloxazine-noradrenaline interaction on the atrium and the isolated ductus defens of the rat. Comparison with imipramine].
    García Morillas M; Puche E; Mundo A; Arias A
    Arch Farmacol Toxicol; 1980 Apr; 6(1):83-8. PubMed ID: 7387207
    [No Abstract]   [Full Text] [Related]  

  • 39. [Viloxazine: its antidepressant action and lack of concomitant anticholinergic effect].
    Marchetti G; Amaducci L; Faravelli C; Matteini P; Pazzagli A
    Riv Patol Nerv Ment; 1977; 98(2):88-98. PubMed ID: 616014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central action of melanostatin (MIF-1) in mice.
    Brus R; Szkilnik R; Stanosek B; Makowska B; Piguła J
    Acta Physiol Pol; 1984; 35(5-6):447-53. PubMed ID: 6152791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.